Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together
RESEARCH ARTICLE (Open Access)

Mpox diagnostics: a swift and integrated approach to outbreak control

Chuan Kok Lim https://orcid.org/0000-0002-2828-2922 A B * , Shivani Pasricha https://orcid.org/0000-0001-9681-1956 A B C and Soo Jen Low A B
+ Author Affiliations
- Author Affiliations

A Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.

B Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.

C Walter and Eliza Hall Institute of Medical Research, Parkville, Vic, Australia.




Dr Chuan Kok Lim is a medical virologist at the Victorian Infectious Diseases Reference Laboratory (VIDRL) and senior research fellow at the Peter Doherty Institute for Infection and Immunity. His research focuses on advancing pandemic preparedness through novel diagnostic development and genomic characterisation of emerging viral pathogens including orthopoxvirus and flavivirus.



Dr Shivani Pasricha is a microbiologist and laboratory head in the Department of Infectious Diseases, The University of Melbourne. Using molecular and genomic approaches, her research aims to improve the detection, prevention and surveillance of sexually transmitted infections (STIs). Her current research includes developing cutting-edge CRISPR-diagnostics for the point-of-care detection of STIs and antimicrobial resistance.



Dr Soo Jen Low is a research officer and bioinformatician at the Peter Doherty Institute for Infection and Immunity. Her research focuses on the application of genomics and development of bioinformatic pipelines to support innovative diagnostic approaches.

* Correspondence to: chuan.lim1@unimelb.edu.au

Microbiology Australia https://doi.org/10.1071/MA24039
Submitted: 1 June 2024  Accepted: 17 June 2024  Published: 8 July 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of the ASM. This is an open access article distributed under the Creative Commons Attribution 4.0 International License (CC BY).

Abstract

The unprecedented global spread of monkeypox (mpox) through physical and sexual transmission revealed significant gaps in diagnostics and sexually transmitted infection (STI) outbreak preparation. An early understanding of viral infectivity and shedding dynamics is critical in informing testing strategies. Capability for viral culture in high-containment laboratories allows rapid dissemination of control materials and evaluation of high-throughput assays, in preparation for testing upscaling. Early genomic characterisation in local clusters informs suitable public health applications and limitations. Monkeypox virus (MPXV) genomics can provide global contextualisation and assist in determining disease importation. As mpox outbreak control strategies evolve towards preventing importation, investment in point-of-care rapid diagnostics such as CRISPR-based lateral flow assays is critical for an agile STI disease-control response.

Keywords: clustered regularly interspaced short palindromic repeats, CRISPR, mpox, monkeypox virus, MPXV, PoCT, point-of-care test, rapid diagnostics, recombinase polymerase amplification, RPA, sexually transmitted infections, STI.

Biographies

MA24039_B1.gif

Dr Chuan Kok Lim is a medical virologist at the Victorian Infectious Diseases Reference Laboratory (VIDRL) and senior research fellow at the Peter Doherty Institute for Infection and Immunity. His research focuses on advancing pandemic preparedness through novel diagnostic development and genomic characterisation of emerging viral pathogens including orthopoxvirus and flavivirus.

MA24039_B2.gif

Dr Shivani Pasricha is a microbiologist and laboratory head in the Department of Infectious Diseases, The University of Melbourne. Using molecular and genomic approaches, her research aims to improve the detection, prevention and surveillance of sexually transmitted infections (STIs). Her current research includes developing cutting-edge CRISPR-diagnostics for the point-of-care detection of STIs and antimicrobial resistance.

MA24039_B3.gif

Dr Soo Jen Low is a research officer and bioinformatician at the Peter Doherty Institute for Infection and Immunity. Her research focuses on the application of genomics and development of bioinformatic pipelines to support innovative diagnostic approaches.

References

Brown K, Leggat PA (2016) Human monkeypox: current state of knowledge and implications for the future. Trop Med Infect Dis 1, 8.
| Crossref | Google Scholar | PubMed |

Liu X et al. (2022) Monkeypox claims new victims: the outbreak in men who have sex with men. Infect Dis Poverty 11, 84.
| Crossref | Google Scholar | PubMed |

Lim CK et al. (2023) Mpox diagnostics: review of current and emerging technologies. J Med Virol 95, e28429.
| Crossref | Google Scholar | PubMed |

Moschese D et al. (2022) Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022. Euro Surveill 27, 2200675.
| Crossref | Google Scholar | PubMed |

Antinori A et al. (2022) Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill 27, 2200421.
| Crossref | Google Scholar | PubMed |

Adler H et al. (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22, 1153-1162.
| Crossref | Google Scholar | PubMed |

Peiró-Mestres A et al. (2022) Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill 27, 2200503.
| Crossref | Google Scholar | PubMed |

Thornhill JP et al. (2022) Monkeypox virus infection in humans across 16 countries — April–June 2022. N Engl J Med 387, 679-691.
| Crossref | Google Scholar | PubMed |

Lim CK et al. (2023) Correlation between monkeypox viral load and infectious virus in clinical specimens. J Clin Virol 161, 105421.
| Crossref | Google Scholar | PubMed |

10  Towns JM et al. (2023) Persistence of monkeypox virus at oral and rectal sites. Lancet Microbe 4, e210.
| Crossref | Google Scholar | PubMed |

11  Batty M et al. (2023) Laboratory assessment of a multi-target assay for the rapid detection of viruses causing vesicular diseases. J Clin Virol 165, 105525.
| Crossref | Google Scholar | PubMed |

12  Iizuka I et al. (2009) Loop-mediated isothermal amplification-based diagnostic assay for monkeypox virus infections. J Med Virol 81, 1102-1108.
| Crossref | Google Scholar | PubMed |

13  Davi SD et al. (2019) Recombinase polymerase amplification assay for rapid detection of monkeypox virus. Diagn Microbiol Infect Dis 95, 41-45.
| Crossref | Google Scholar | PubMed |

14  Papadakis G et al. (2023) Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses. J Clin Virol 161, 105424.
| Crossref | Google Scholar | PubMed |

15  WHO Surveillance Systems (2024) Diagnostic testing for the monkeypox virus (‎MPXV)‎: interim guidance, 10 May 2024. Technical document. World Health Organization. https://www.who.int/publications/i/item/WHO-MPX-Laboratory-2024.1

16  Taouk ML et al. (2023) Intra‐ and interhost genomic diversity of monkeypox virus. J Med Virol 95, e29029.
| Crossref | Google Scholar | PubMed |

17  Borges V et al. (2023) Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal. Nat Med 29, 2509-2517.
| Crossref | Google Scholar | PubMed |

18  Ahmed SF et al. (2022) Vaccinia-virus-based vaccines are expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus. Viruses 14, 1960.
| Crossref | Google Scholar | PubMed |

19  Cunningham CH et al. (2021) A novel CRISPR-based malaria diagnostic capable of Plasmodium detection, species differentiation, and drug-resistance genotyping. EBioMedicine 68, 103415.
| Crossref | Google Scholar | PubMed |

20  Gootenberg JS et al. (2018) Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360, 439-444.
| Crossref | Google Scholar | PubMed |

21  Kellner MJ et al. (2019) SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc 14, 2986-3012.
| Crossref | Google Scholar | PubMed |

22  Mustafa MI, Makhawi AM (2021) SHERLOCK and DETECTR: CRISPR–Cas systems as potential rapid diagnostic tools for emerging infectious diseases. J Clin Microbiol 59(3), e00745-20.
| Crossref | Google Scholar | PubMed |

23  Low SJ et al. (2024) PathoGD: an integrative genomics approach for CRISPR-based target design of rapid pathogen diagnostics. bioRxiv 2024.05.14.593882 [Preprint, posted 15 May 2024].
| Crossref | Google Scholar |

24  Khalil A et al. (2023) The need for better diagnostics to support diagnosis and surveillance in monkeypox endemic countries. Lancet Microbe 4, e67.
| Crossref | Google Scholar | PubMed |

25  Low SJ et al. (2023) Rapid detection of monkeypox virus using a CRISPR–Cas12a mediated assay: a laboratory validation and evaluation study. Lancet Microbe 4, e800-e810.
| Crossref | Google Scholar | PubMed |